Month |
Date |
Speaker |
Title |
|
|
|
|
August |
28 |
Dr. Michael Henry
Department of Molecular Physiology and Biophysics, UI |
Androgen Receptor-targeted siRNA Therapy for Advanced Prostate Cancer |
|
|
|
|
September |
4 |
Dr. Dirk Trauner
University of California, Berkeley |
Synthetic Studies on Natural Products and Neurons |
|
11 |
Dr. Judy Bolton
University of Illinois at Chicago |
Quinoids from selective estrogen receptor modulators (SERMs): Biological Consequences? |
|
18 |
Rachel Miller
Medicinal and Natural Products Chemistry,UI |
Cancelled / to be rescheduled |
|
25 |
Dr. Jef De Brabander
University of Texas Southwestern Medical Center |
Natural Products: Opportunities for Discovery |
|
|
|
|
October |
2 |
Dr. Iwao Ojima
State University of New York at Stony Brook |
New molecular strategies for tumor-targeting chemotherapy |
|
9 |
Nadezhda German
Thesis Seminar
Medicinal and Natural Products Chemistry, UI |
Design and Synthesis of Novel Molecules for Overcoming Bacterial Resistance to Fluoroquinolones |
|
16 |
Molly Martin
Thesis Seminar
Medicinal and Natural Products Chemistry, UI |
Design and Testing of Novel Intrinsic Proteasome Inhibitory Gene Transfer Peptides |
|
23 |
Center for Biocatalysis and Bioprocessing Symposium – No MNPC Seminar |
|
|
25 |
Faculty Candidate Seminar |
|
|
|
|
|
November |
6 |
Faculty Candidate Seminar |
|
|
15 |
Faculty Candidate Seminar (Note: Thursday) |
|
|
20 |
Thanksgiving Recess - No Seminar |
|
|
29 |
Faculty Candidate Seminar |
|
|
|
|
|
December |
4 |
Dr. Emily Scott
University of Kansas |
Structural Differences Between Human Lung and Liver Cytochrome P450s That Matter in Drug Metabolism and Procarcinogen Activation |
|
18 |
Kevin Marks
Medicinal and Natural Products Chemistry, UI
|
Napthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: A Potent, Orally Bioavailable Human CB1/CB2 Dual Agonist with Antihyperalgesic Properties and Restricted Central Nervous System Penetration |
| |
|
|
|
| January |
29 |
Dr. Sue O'Dorisio
Department of Pediatrics, UI |
G Protein Coupled Receptors as Molecular Targets in PET Imaging and Radiopeptide Therapy of Pediatric Tumors |
| |
|
|
|
| February |
5 |
Erin Gagan, Medicinal and Natural Products Chemistry, UI |
Synthesis and simple 18F-Labeling of 3-Fluoro-5-(2-(2-(fluoromethyl)thiazol-4-yl)ethynyl) benzonitrile as a high affinity radioligand for imaging monkey brain metabotropic glutamate subtype-5 receptors with Positron Emission Tomography |
| |
12 |
Amanda Fenner, Medicinal and Natural Products Chemistry, UI |
2H-Benzimidazole 1,3-Dioxide Derivatives: A New Family of Water-Soluble Anti-Trypanosomatid Agents |
| |
19 |
Dr. Francisco Velázquez,Schering-Plough Research Institute, Kenilworth, NJ |
Synthesis and Evaluation of HCV NS3 Protease Inhibitors |
| |
26 |
Dr. Curtis D. Klaassen, University of Kansas Medical Center, Kansas City, KS |
Hepatobiliary Disposition of Xenobiotics |
| |
|
|
|
| March |
4 |
Dr. Victoria Roche, Creighton University, Omaha, NE |
Let’s Have Some Fun! Advancing Learning with Computerized Medicinal Chemistry Case Studies |
| |
25 |
Dr. Paloma Giangrande, Department of Cardiology, UI |
RNA Aptamers: Platform Technology for Targeted Therapies |
| |
|
|
|
| April |
15 |
Dr. Dennis R. Petersen, University of Colorado, Denver, CO |
Proteomic insights into interactions of 4-hydroxynonenal and 4-oxononenal on hepatic proteins prepared from rats ingesting alcohol |
| |
|
|
|
| May |
6 |
Dr. Chris Pigge
Department of Chemistry,
UI |
|
